Quick Answer
ImageneBio, Inc. reported Stockholders Equity of $133.14 million for fiscal year 2025.
ImageneBio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $133.14M | +182.9% |
| 2024 | -$160.56M | -27.3% |
| 2023 | -$126.11M | -185.8% |
| 2022 | $146.97M | -29.3% |
| 2021 | $207.88M | +305.7% |
| 2020 | -$101.05M | -64.4% |
| 2019 | -$61.46M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $139.83M | +191.5% | +177.5% |
| June 30, 2025 | -$180.35M | -23.0% | -6.3% |
| March 31, 2025 | -$169.60M | -23.5% | -5.6% |
| December 31, 2024 | -$160.56M | -27.3% | -5.1% |
| September 30, 2024 | -$152.75M | -198.3% | -4.2% |
| June 30, 2024 | -$146.57M | -193.5% | -6.7% |
| March 31, 2024 | -$137.35M | -201.7% | -8.9% |
| December 31, 2023 | -$126.11M | -185.8% | -181.2% |
- ImageneBio, Inc. showed an increase of +182.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, ImageneBio, Inc.’s stockholders equity has grown by 316.6% (from -$61.46 million to $133.14 million).
- The most recent figure is from ImageneBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: